We are live on
!
Find out more
WM
WS Management Portfolio holdings
AUM
$1.13B
1-Year Est. Return
53.44%
This Fund
S&P 500
This Quarter
Est. Return
+2.62%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$1.54B
AUM Growth
-$109M
(-6.6%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-7.73%
Top 10 Holdings %
Top 10 Hldgs %
61.5%
Holding
73
New
8
Increased
5
Reduced
52
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$92.5M |
| 2 |
SPDR Gold Trust
GLD
|
+$43M |
| 3 |
NVIDIA
NVDA
|
+$8.53M |
| 4 |
Zillow
Z
|
+$7.97M |
| 5 |
Regenxbio
RGNX
|
+$198K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$146M |
| 2 |
Micron Technology
MU
|
+$21.3M |
| 3 |
SAFM
Sanderson Farms Inc
SAFM
|
+$16.6M |
| 4 |
CarMax
KMX
|
+$14.2M |
| 5 |
ATI
ATI
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.6% |
| 2 | Consumer Discretionary | 10.22% |
| 3 | Communication Services | 7.71% |
| 4 | Industrials | 7.66% |
| 5 | Healthcare | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
SLB Ltd
SLB
$76.5B
| $5.11M | 0.33% |
128,457
-13,702
| -10% | -$552K |
|
|
BOLD
52
DELISTED
Audentes Therapeutics, Inc
BOLD
| $4.98M | 0.32% |
131,495
-12,527
| -9% | -$481K |
|
53
BioMarin Pharmaceuticals
BMRN
$11.6B
| $3.83M | 0.25% |
44,775
-5,467
| -11% | -$468K |
|
|
AUD
54
DELISTED
Audacy, Inc.
AUD
| $2.53M | 0.16% |
435,860
-11,121
| -2% | -$68.3K |
|
|
BLUE
55
DELISTED
bluebird bio
BLUE
| $2.05M | 0.13% |
1,244
-147
| -11% | -$254K |
|
|
SAFM
56
DELISTED
Sanderson Farms Inc
SAFM
| $1.63M | 0.11% |
11,900
-117,019
| -91% | -$16.6M |
|
57
Wave Life Sciences
WVE
$1.14B
| $1.61M | 0.1% |
61,585
-7,392
| -11% | -$207K |
|
58
Ultragenyx Pharmaceutical
RARE
$2.65B
| $1.45M | 0.09% |
22,824
-2,704
| -11% | -$172K |
|
59
CRISPR Therapeutics
CRSP
$4.6B
| $1.28M | 0.08% |
27,112
-3,204
| -11% | -$128K |
|
|
SGMO
60
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.25M | 0.08% |
115,739
-13,633
| -11% | -$145K |
|
|
CLLS
61
Cellectis
CLLS
$291M
| $1.14M | 0.07% |
73,124
-8,648
| -11% | -$154K |
|
62
Editas Medicine
EDIT
$411M
| $1.02M | 0.07% |
41,372
-4,898
| -11% | -$117K |
|
63
Intellia Therapeutics
NTLA
$1.49B
| $940K | 0.06% |
57,392
-6,776
| -11% | -$107K |
|
|
ADAP
64
DELISTED
Adaptimmune Therapeutics
ADAP
| $667K | 0.04% |
165,947
-19,590
| -11% | -$79.9K |
|
65
Abeona Therapeutics
ABEO
$349M
| $634K | 0.04% |
5,305
-625
| -11% | -$105K |
|
66
PUT
Alibaba
BABA
$276B
| – | – |
-100,000
| Closed | -$18.2M |
|
67
CALL
Enterprise Products Partners
EPD
$82.5B
| – | – |
-200,000
| Closed | -$5.82M |
|
68
JetBlue
JBLU
$2.02B
| – | – |
-526,762
| Closed | -$8.62M |
|
|
69
PUT
Micron Technology
MU
$1.02T
| – | – |
-300,000
| Closed | -$12.4M |
|
70
uniQure
QURE
$2.63B
| – | – |
-60,304
| Closed | -$3.6M |
|
71
Stellantis
STLA
$16.5B
| – | – |
-541,211
| Closed | -$8.04M |
|
|
AMRS
72
DELISTED
Amyris Inc.
AMRS
| – | – |
-550,319
| Closed | -$1.15M |
|
|
GRUB
73
PUT
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| – | – |
-22,500
| Closed | -$3.13M |
|
Similar funds
OHIF
HMCP
SAM
AT
ACM
IP
PFCS
PL
WS Management's Q2 2019 Portfolio in Review
As of Q2 2019, WS Management held 73 positions worth $1.54B, down 6.6% from $1.65B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
WS Management withdrew a net $119M in Q2 2019, closing 8 positions and reducing 52 holdings. Its most notable exit was JetBlue, an estimated $8.62M position sold in full.
By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, WS Management opened a new position in NVIDIA worth $8.45M.
- WS Management's largest Q2 2019 buy was NVIDIA: 2,058,640 shares worth $8.45M.
- WS Management added most to Berkshire Hathaway Class B in Q2 2019, an estimated $92.5M increase.
- WS Management's biggest Q2 2019 reduction was Berkshire Hathaway Class A, cutting an estimated $146M.
- WS Management fully exited JetBlue in Q2 2019, selling an estimated $8.62M.
- WS Management's ten largest holdings make up 62% of its $1.54B portfolio in Q2 2019.
- WS Management opened 8 new positions and closed 8 in Q2 2019.
- WS Management's portfolio value fell 6.6% quarter-over-quarter to $1.54B.
Based on WS Management's 13F filing for Q2 2019, filed 13 Aug 2019.